Vinge has advised Isofol Medical AB (publ), Nasdaq First North Premier Growth Market, in connection with a fully guaranteed rights issue and exercised over-allotment option which together add SEK 500 million to Isofol before transaction costs.
Vinge’s team primarily consisted of Anders Strid, Edin Agic, Jenny Sandlund and Beatrice Randow.
